The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
SID92764498 ID: ALA1710607
Chembl Id: CHEMBL1710607
PubChem CID: 269180
Max Phase: Preclinical
Molecular Formula: C16H12FN
Molecular Weight: 237.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc2ccccc2nc1-c1ccccc1F
Standard InChI: InChI=1S/C16H12FN/c1-11-10-12-6-2-5-9-15(12)18-16(11)13-7-3-4-8-14(13)17/h2-10H,1H3
Standard InChI Key: HECMNZNMEOFMGF-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 237.28Molecular Weight (Monoisotopic): 237.0954AlogP: 4.35#Rotatable Bonds: 1Polar Surface Area: 12.89Molecular Species: NEUTRALHBA: 1HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 1HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.04CX LogP: 4.82CX LogD: 4.82Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.61Np Likeness Score: -0.94
References 1. PubChem BioAssay data set, 2. Ahamad S, Bhat SA.. (2022) The Emerging Landscape of Small-Molecule Therapeutics for the Treatment of Huntington's Disease., 65 (24.0): [PMID:36490325 ] [10.1021/acs.jmedchem.2c00799 ]